Ashraf Khalil

1.6k total citations
37 papers, 1.2k citations indexed

About

Ashraf Khalil is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Ashraf Khalil has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Neurology. Recurrent topics in Ashraf Khalil's work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Ashraf Khalil is often cited by papers focused on Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Ashraf Khalil collaborates with scholars based in Qatar, United States and Canada. Ashraf Khalil's co-authors include Neal Castagnoli, Dale E. Edmondson, Claudia Binda, Kristoffer Valerie, Sarah E. Golding, Ala‐Eddin Al Moustafa, Elizabeth Rosenberg, Andrea Mattevi, František Hubálek and Lawrence F. Povirk and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Ashraf Khalil

35 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ashraf Khalil

Since Specialization

Citations

This map shows the geographic impact of Ashraf Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Khalil more than expected).

Fields of papers citing papers by Ashraf Khalil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Khalil. The network helps show where Ashraf Khalil may publish in the future.

Co-authorship network of co-authors of Ashraf Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Khalil. A scholar is included among the top collaborators of Ashraf Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Khalil. Ashraf Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liposomal delivery of DK14 chalcone analogue: A promising therapeutic strategy against triple-negative breast cancer 2025 ·Journal of Drug Delivery Science and Technology ·Ahmed Suliman, (unknown), (unknown), (unknown), Ashraf Khalil, Abdelbary Elhissi	1
2	The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Feras Q. Alali, Ala‐Eddin Al Moustafa, Ashraf Khalil	0
3	The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways 2024 ·Heliyon ·(unknown), (unknown), (unknown), Asma Allouch, Layla Kamareddine, Ahmed Malki, Ala‐Eddin Al Moustafa, Ashraf Khalil	3
4	Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials 2023 ·Frontiers in Oncology ·(unknown), (unknown), Ahmed Awaisu, Feras Q. Alali, Ashraf Khalil	5
5	Elaeagnus angustifolia Plant Extract Induces Apoptosis via P53 and Signal Transducer and Activator of Transcription 3 Signaling Pathways in Triple-Negative Breast Cancer Cells 2022 ·Frontiers in Nutrition ·(unknown), (unknown), Ishita Gupta, (unknown), Ashraf Khalil, Ala‐Eddin Al Moustafa	17
6	Recent advances in stimuli-responsive drug release and targeting concepts using mesoporous silica nanoparticles 2020 ·Emergent Materials ·(unknown), Moustafa M. Zagho, Ashraf Khalil	49
7	Novel Polymethoxylated Chalcones as Potential Compounds Against KRAS-Mutant Colorectal Cancers 2020 ·Current Pharmaceutical Design ·(unknown), (unknown), Feras Q. Alali, Ala‐Eddin Al Moustafa, Ashraf Khalil	9
8	A comprehensive review on the antiviral activities of chalcones 2020 ·Journal of drug targeting ·(unknown), (unknown), Ala‐Eddin Al Moustafa, Ashraf Khalil	99
9	Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer 2019 ·European Journal of Medicinal Chemistry ·(unknown), Abu Bakar Siddique, (unknown), Farhan Cyprian, Khalid A. El Sayed, Feras Q. Alali, Ala‐Eddin Al Moustafa, Ashraf Khalil	42
10	SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs 2019 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), Jacobus P. Petzer, Anél Petzer, Usman Ashraf, (unknown), Fawaz Alasmari, Sivarajan Kumarasamy, (unknown), Ashraf Khalil	50
11	Targeting triple negative breast cancer heterogeneity with chalcones: a molecular insight 2018 ·Journal of drug targeting ·(unknown), Feras Q. Alali, Ala‐Eddin Al Moustafa, Ashraf Khalil	17
12	Teucrium Polium Plant Extract Provokes Substantial Cytotoxicity at the Early Stage of Embryonic Development 2018 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Tahar Aboulkassim, Semir Vranić, Ala‐Eddin Al Moustafa, Ashraf Khalil	10
13	Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease 2015 ·CNS & Neurological Disorders - Drug Targets ·(unknown), Ashraf Khalil	30
14	ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation 2013 ·Clinical Cancer Research ·(unknown), Sajjad Muhammad, Elizabeth Rosenberg, Jason M. Beckta, Nicholas C.K. Valerie, Mary Tokarz, Bret R. Adams, Alison F. Wagner, Ashraf Khalil, Donna Gilfor, Sarah E. Golding, Sumitra Deb, (unknown), Alan Lau, Mark J. O’Connor, Kevin S. Choe, Luis F. Parada, Sang Kyun Lim, Nitai D. Mukhopadhyay, Kristoffer Valerie	150
15	DNA double-strand break – induced pro-survival signaling 2011 ·Radiotherapy and Oncology ·Amy J. Hawkins, Sarah E. Golding, Ashraf Khalil, Kristoffer Valerie	38
16	Synthesis, in‐vitro Cytotoxicity, and a Preliminary Structure‐Activity Relationship Investigation of Pyrimido[4,5‐c]quinolin‐1(2H)‐ones 2010 ·Archiv der Pharmazie ·Kamel Metwally, Ashraf Khalil, Harris Pratsinis, Dimitris Kletsas	7
17	A novel and selective monoamine oxidase B substrate 2005 ·Bioorganic & Medicinal Chemistry ·John M. Rimoldi, (unknown), Emre M. Isin, Philippe Bissel, Ashraf Khalil, Neal Castagnoli	8
18	Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors 2005 ·Journal of Biological Chemistry ·František Hubálek, Claudia Binda, Ashraf Khalil, (unknown), Andrea Mattevi, Neal Castagnoli, Dale E. Edmondson	193
19	Double Strand Break Repair by Homologous Recombination Is Regulated by Cell Cycle-independent Signaling via ATM in Human Glioma Cells 2004 ·Journal of Biological Chemistry ·Sarah E. Golding, Elizabeth Rosenberg, Ashraf Khalil, (unknown), Matthew Holmes, Steven J. Neill, Lawrence F. Povirk, Kristoffer Valerie	98
20	Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase 2002 ·Neurotoxicity Research ·Kay Castagnoli, Stefanus J. Steyn, Géraldine Magnin, Cornelis J. Van der Schyf, (unknown), Ashraf Khalil, Neal Castagnoli	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact